Plain-English translation of NCT06974474 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing a medication called to see if it can help reduce pain in people with psoriatic arthritis — a condition that causes joint inflammation and pain. Researchers want to understand not just whether this medication works, but also how it works at a biological level to change how your body experiences pain. Earlier studies showed promise, and now researchers want to explore the deeper mechanisms behind its pain-relieving effects.
Pain is the most common symptom that bothers people with psoriatic arthritis, yet doctors don't fully understand all the ways it develops. This medication targets a specific pathway in the immune system that may be involved in pain perception, and researchers want to confirm this mechanism and measure it carefully in patients like you.
You likely qualify if…
You likely don't qualify if…
You will receive as your treatment for psoriatic arthritis, either on its own or combined with methotrexate if your doctor recommends it. Throughout the study, researchers will monitor how the medication affects your pain using questionnaires and blood tests, and they will also perform special tests to measure how your nervous system perceives pain. The exact schedule of visits and duration will be determined by the research team, but you can expect regular follow-up appointments to track your progress and gather detailed information about how the treatment is working.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Italy